Placement of Aortic Transcatheter Valves (PARTNER) trial
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:compared |
transcatheter aortic valve implantation
surgical aortic valve replacement |
| gptkbp:enrolledPatients |
over 1000
|
| https://www.w3.org/2000/01/rdf-schema#label |
Placement of Aortic Transcatheter Valves (PARTNER) trial
|
| gptkbp:location |
gptkb:Canada
gptkb:Germany gptkb:United_States |
| gptkbp:period |
Phase 3
|
| gptkbp:principalInvestigator |
gptkb:Craig_R._Smith
gptkb:Martin_B._Leon |
| gptkbp:publishedIn |
gptkb:New_England_Journal_of_Medicine
|
| gptkbp:registration |
gptkb:NCT00530894
|
| gptkbp:result |
TAVR non-inferior to surgery in high-risk patients
all-cause mortality TAVR superior to medical therapy in inoperable patients cardiovascular mortality |
| gptkbp:sponsor |
gptkb:Edwards_Lifesciences
|
| gptkbp:startYear |
2007
|
| gptkbp:studiedBy |
severe aortic stenosis
transcatheter aortic valve replacement |
| gptkbp:bfsParent |
gptkb:PARTNER_trial
|
| gptkbp:bfsLayer |
8
|